Admixture mapping of African-American women in the AMBER Consortium identifies new loci for breast cancer and estrogen-receptor subtypes

Edward A. Ruiz-Narváez, Lara Sucheston-Campbell, Jeannette T. Bensen, Song Yao, Stephen Haddad, Christopher A. Haiman, Elisa V. Bandera, Esther M. John, Leslie Bernstein, Jennifer Hu, Regina G. Ziegler, Sandra L. Deming, Andrew F. Olshan, Christine B. Ambrosone, Julie R. Palmer, Kathryn L. Lunetta

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Recent genetic admixture coupled with striking differences in incidence of estrogen receptor (ER) breast cancer subtypes, as well as severity, between women of African and European ancestry, provides an excellent rationale for performing admixture mapping in African American women with breast cancer risk. We performed the largest breast cancer admixture mapping study with in African American women to identify novel genomic regions associated with the disease. We conducted a genome-wide admixture scan using 2,624 autosomal ancestry informative markers (AIMs) in 3,629 breast cancer cases (including 1,968 ER-positive, 1093 ER-negative, and 601 triple-negative) and 4,658 controls from the African American Breast Cancer Epidemiology and Risk (AMBER) Consortium, a collaborative study of four large geographically different epidemiological studies of breast cancer in African American women. We used an independent case-control study to test for SNP association in regions with genome-wide significant admixture signals. We found two novel genome-wide significant regions of excess African ancestry, 4p16.1 and 17q25.1, associated with ER-positive breast cancer. Two regions known to harbor breast cancer variants, 10q26 and 11q13, were also identified with excess of African ancestry. Fine-mapping of the identified genome-wide significant regions suggests the presence of significant genetic associations with ER-positive breast cancer in 4p16.1 and 11q13. In summary, we identified three novel genomic regions associated with breast cancer risk by ER status, suggesting that additional previously unidentified variants may contribute to the racial differences in breast cancer risk in the African American population.

Original languageEnglish (US)
Article number170
JournalFrontiers in Genetics
Volume7
Issue numberSEP
DOIs
StatePublished - Sep 21 2016

Fingerprint

Estrogen Receptors
African Americans
Epidemiology
Breast Neoplasms
Genome
Chromosome Mapping
Single Nucleotide Polymorphism
Case-Control Studies
Epidemiologic Studies
Incidence

Keywords

  • Admixture mapping
  • African American women
  • Breast cancer
  • Fine-mapping
  • Genetics

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Genetics(clinical)

Cite this

Ruiz-Narváez, E. A., Sucheston-Campbell, L., Bensen, J. T., Yao, S., Haddad, S., Haiman, C. A., ... Lunetta, K. L. (2016). Admixture mapping of African-American women in the AMBER Consortium identifies new loci for breast cancer and estrogen-receptor subtypes. Frontiers in Genetics, 7(SEP), [170]. https://doi.org/10.3389/fgene.2016.00170

Admixture mapping of African-American women in the AMBER Consortium identifies new loci for breast cancer and estrogen-receptor subtypes. / Ruiz-Narváez, Edward A.; Sucheston-Campbell, Lara; Bensen, Jeannette T.; Yao, Song; Haddad, Stephen; Haiman, Christopher A.; Bandera, Elisa V.; John, Esther M.; Bernstein, Leslie; Hu, Jennifer; Ziegler, Regina G.; Deming, Sandra L.; Olshan, Andrew F.; Ambrosone, Christine B.; Palmer, Julie R.; Lunetta, Kathryn L.

In: Frontiers in Genetics, Vol. 7, No. SEP, 170, 21.09.2016.

Research output: Contribution to journalArticle

Ruiz-Narváez, EA, Sucheston-Campbell, L, Bensen, JT, Yao, S, Haddad, S, Haiman, CA, Bandera, EV, John, EM, Bernstein, L, Hu, J, Ziegler, RG, Deming, SL, Olshan, AF, Ambrosone, CB, Palmer, JR & Lunetta, KL 2016, 'Admixture mapping of African-American women in the AMBER Consortium identifies new loci for breast cancer and estrogen-receptor subtypes', Frontiers in Genetics, vol. 7, no. SEP, 170. https://doi.org/10.3389/fgene.2016.00170
Ruiz-Narváez, Edward A. ; Sucheston-Campbell, Lara ; Bensen, Jeannette T. ; Yao, Song ; Haddad, Stephen ; Haiman, Christopher A. ; Bandera, Elisa V. ; John, Esther M. ; Bernstein, Leslie ; Hu, Jennifer ; Ziegler, Regina G. ; Deming, Sandra L. ; Olshan, Andrew F. ; Ambrosone, Christine B. ; Palmer, Julie R. ; Lunetta, Kathryn L. / Admixture mapping of African-American women in the AMBER Consortium identifies new loci for breast cancer and estrogen-receptor subtypes. In: Frontiers in Genetics. 2016 ; Vol. 7, No. SEP.
@article{d4ed828fd75344a5ab30c1be8b763cac,
title = "Admixture mapping of African-American women in the AMBER Consortium identifies new loci for breast cancer and estrogen-receptor subtypes",
abstract = "Recent genetic admixture coupled with striking differences in incidence of estrogen receptor (ER) breast cancer subtypes, as well as severity, between women of African and European ancestry, provides an excellent rationale for performing admixture mapping in African American women with breast cancer risk. We performed the largest breast cancer admixture mapping study with in African American women to identify novel genomic regions associated with the disease. We conducted a genome-wide admixture scan using 2,624 autosomal ancestry informative markers (AIMs) in 3,629 breast cancer cases (including 1,968 ER-positive, 1093 ER-negative, and 601 triple-negative) and 4,658 controls from the African American Breast Cancer Epidemiology and Risk (AMBER) Consortium, a collaborative study of four large geographically different epidemiological studies of breast cancer in African American women. We used an independent case-control study to test for SNP association in regions with genome-wide significant admixture signals. We found two novel genome-wide significant regions of excess African ancestry, 4p16.1 and 17q25.1, associated with ER-positive breast cancer. Two regions known to harbor breast cancer variants, 10q26 and 11q13, were also identified with excess of African ancestry. Fine-mapping of the identified genome-wide significant regions suggests the presence of significant genetic associations with ER-positive breast cancer in 4p16.1 and 11q13. In summary, we identified three novel genomic regions associated with breast cancer risk by ER status, suggesting that additional previously unidentified variants may contribute to the racial differences in breast cancer risk in the African American population.",
keywords = "Admixture mapping, African American women, Breast cancer, Fine-mapping, Genetics",
author = "Ruiz-Narv{\'a}ez, {Edward A.} and Lara Sucheston-Campbell and Bensen, {Jeannette T.} and Song Yao and Stephen Haddad and Haiman, {Christopher A.} and Bandera, {Elisa V.} and John, {Esther M.} and Leslie Bernstein and Jennifer Hu and Ziegler, {Regina G.} and Deming, {Sandra L.} and Olshan, {Andrew F.} and Ambrosone, {Christine B.} and Palmer, {Julie R.} and Lunetta, {Kathryn L.}",
year = "2016",
month = "9",
day = "21",
doi = "10.3389/fgene.2016.00170",
language = "English (US)",
volume = "7",
journal = "Frontiers in Genetics",
issn = "1664-8021",
publisher = "Frontiers Media S. A.",
number = "SEP",

}

TY - JOUR

T1 - Admixture mapping of African-American women in the AMBER Consortium identifies new loci for breast cancer and estrogen-receptor subtypes

AU - Ruiz-Narváez, Edward A.

AU - Sucheston-Campbell, Lara

AU - Bensen, Jeannette T.

AU - Yao, Song

AU - Haddad, Stephen

AU - Haiman, Christopher A.

AU - Bandera, Elisa V.

AU - John, Esther M.

AU - Bernstein, Leslie

AU - Hu, Jennifer

AU - Ziegler, Regina G.

AU - Deming, Sandra L.

AU - Olshan, Andrew F.

AU - Ambrosone, Christine B.

AU - Palmer, Julie R.

AU - Lunetta, Kathryn L.

PY - 2016/9/21

Y1 - 2016/9/21

N2 - Recent genetic admixture coupled with striking differences in incidence of estrogen receptor (ER) breast cancer subtypes, as well as severity, between women of African and European ancestry, provides an excellent rationale for performing admixture mapping in African American women with breast cancer risk. We performed the largest breast cancer admixture mapping study with in African American women to identify novel genomic regions associated with the disease. We conducted a genome-wide admixture scan using 2,624 autosomal ancestry informative markers (AIMs) in 3,629 breast cancer cases (including 1,968 ER-positive, 1093 ER-negative, and 601 triple-negative) and 4,658 controls from the African American Breast Cancer Epidemiology and Risk (AMBER) Consortium, a collaborative study of four large geographically different epidemiological studies of breast cancer in African American women. We used an independent case-control study to test for SNP association in regions with genome-wide significant admixture signals. We found two novel genome-wide significant regions of excess African ancestry, 4p16.1 and 17q25.1, associated with ER-positive breast cancer. Two regions known to harbor breast cancer variants, 10q26 and 11q13, were also identified with excess of African ancestry. Fine-mapping of the identified genome-wide significant regions suggests the presence of significant genetic associations with ER-positive breast cancer in 4p16.1 and 11q13. In summary, we identified three novel genomic regions associated with breast cancer risk by ER status, suggesting that additional previously unidentified variants may contribute to the racial differences in breast cancer risk in the African American population.

AB - Recent genetic admixture coupled with striking differences in incidence of estrogen receptor (ER) breast cancer subtypes, as well as severity, between women of African and European ancestry, provides an excellent rationale for performing admixture mapping in African American women with breast cancer risk. We performed the largest breast cancer admixture mapping study with in African American women to identify novel genomic regions associated with the disease. We conducted a genome-wide admixture scan using 2,624 autosomal ancestry informative markers (AIMs) in 3,629 breast cancer cases (including 1,968 ER-positive, 1093 ER-negative, and 601 triple-negative) and 4,658 controls from the African American Breast Cancer Epidemiology and Risk (AMBER) Consortium, a collaborative study of four large geographically different epidemiological studies of breast cancer in African American women. We used an independent case-control study to test for SNP association in regions with genome-wide significant admixture signals. We found two novel genome-wide significant regions of excess African ancestry, 4p16.1 and 17q25.1, associated with ER-positive breast cancer. Two regions known to harbor breast cancer variants, 10q26 and 11q13, were also identified with excess of African ancestry. Fine-mapping of the identified genome-wide significant regions suggests the presence of significant genetic associations with ER-positive breast cancer in 4p16.1 and 11q13. In summary, we identified three novel genomic regions associated with breast cancer risk by ER status, suggesting that additional previously unidentified variants may contribute to the racial differences in breast cancer risk in the African American population.

KW - Admixture mapping

KW - African American women

KW - Breast cancer

KW - Fine-mapping

KW - Genetics

UR - http://www.scopus.com/inward/record.url?scp=84992448421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992448421&partnerID=8YFLogxK

U2 - 10.3389/fgene.2016.00170

DO - 10.3389/fgene.2016.00170

M3 - Article

AN - SCOPUS:84992448421

VL - 7

JO - Frontiers in Genetics

JF - Frontiers in Genetics

SN - 1664-8021

IS - SEP

M1 - 170

ER -